Clinical trial of WT1 peptide therapy after WT1 and/or tumor lysates-pulsed dendritic cell vaccination therapy for patients with malignant glioma

Trial Profile

Clinical trial of WT1 peptide therapy after WT1 and/or tumor lysates-pulsed dendritic cell vaccination therapy for patients with malignant glioma

Recruiting
Phase of Trial: Phase I

Latest Information Update: 15 Sep 2012

At a glance

  • Drugs Picibanil (Primary) ; WT1 peptide vaccine (Primary)
  • Indications Glioma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top